title: Management of antithrombotic drugs in association with endoscopic procedures.
abstract: The use of antithrombotic drugs (anticoagulants and antiplatelets) has increased significantly with our understanding of cardiovascular risk. Encountering patients on these therapies who require an endoscopic procedure is therefore increasingly common. At decision making the endoscopist must rely on other specialists (basically cardiologists and hematologists) as risk not only lies among increased bleeding odds but also in the possibility of thrombosis following dose discontinuation or change. Understanding the pharmacology, indications, and risks of endoscopic procedures is therefore essential if sound decisions are to be made. The efforts of four scientific societies have been brought together to provide clinical answers on the use of antiplatelets and anticoagulants, as well as action algorithms and a practical protocol proposal for endoscopy units.
authors.forename: Fernando
authors.initials: F
authors.lastname: Alberca-de-Las-Parras
authors.forename: Francisco
authors.initials: F
authors.lastname: Marín
authors.forename: Vanessa
authors.initials: V
authors.lastname: Roldán-Schilling
authors.forename: Fernando
authors.initials: F
authors.lastname: Carballo-Álvarez
mesh_terms: D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D000066491:Clinical Decision-Making / Q000379:methods*; D000075202:Contraindications; D003661:Decision Support Techniques; D016145:Endoscopy, Digestive System / Q000009:adverse effects; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D018570:Risk Assessment; D013030:Spain; D028761:Withholding Treatment
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors